Denver Investment Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$1.98M Sell
27,320
-482
-2% -$36.7K 0.1% 172
2017
Q4
$2.09M Buy
27,802
+391
+1% +$29.5K 0.1% 170
2017
Q3
$2.11M Hold
27,411
0.1% 172
2017
Q2
$2.05M Sell
27,411
-1
-0% -$71 0.09% 183
2017
Q1
$1.82M Buy
27,412
+892
+3% +$59.4K 0.08% 194
2016
Q4
$1.73M Buy
26,520
+4,324
+19% +$280K 0.07% 203
2016
Q3
$1.57M Buy
22,196
+2,332
+12% +$170K 0.07% 215
2016
Q2
$1.47M Sell
19,864
-139
-0.7% -$9.6K 0.07% 220
2016
Q1
$1.3M Buy
20,003
+579
+3% +$39.4K 0.06% 243
2015
Q4
$1.5M Buy
19,424
+672
+4% +$53.4K 0.07% 230
2015
Q3
$1.54M Sell
18,752
-1,356
-7% -$121K 0.07% 224
2015
Q2
$1.77M Hold
20,108
0.07% 228
2015
Q1
$1.78M Sell
20,108
-3,153
-14% -$280K 0.06% 292
2014
Q4
$1.93M Hold
23,261
0.06% 279
2014
Q3
$1.96M Sell
23,261
-4,575
-16% -$370K 0.06% 275
2014
Q2
$2.26M Sell
27,836
-2,456
-8% -$193K 0.07% 275
2014
Q1
$2.31M Sell
30,292
-1,004
-3% -$73.2K 0.07% 284
2013
Q4
$2.25K Sell
31,296
-4,982
-14% -$346K 0.06% 295
2013
Q3
$2.49M Buy
36,278
+223
+0.6% +$14.8K 0.05% 315
2013
Q2
$2.28M Buy
+36,055
New +$2.35M 0.05% 299

Other funds holding NVS

Denver Investment Advisors's NVS Position: Q1 2018 in Review

Denver Investment Advisors reduced its Novartis (NVS) stake by 1.7% in Q1 2018, selling an estimated $36.7K and leaving 27,320 shares worth $1.98M. The position accounts for 0.1% of the portfolio, ranked #172.

Denver Investment Advisors first reported a position in NVS in Q2 2013 and has held it in 20 quarters since. The position peaked at $2.49M in Q3 2013. 1,013 funds tracked by Wall St. Rank hold NVS as of Q1 2018.

  • Denver Investment Advisors held 27,320 shares of Novartis worth $1.98M as of Q1 2018.
  • Denver Investment Advisors sold 482 Novartis shares in Q1 2018, an estimated $36.7K.
  • Novartis made up 0.1% of Denver Investment Advisors's portfolio in Q1 2018, its #172 holding.
  • Denver Investment Advisors first reported a position in Novartis in Q2 2013 and has held it in 20 quarters since.
  • Denver Investment Advisors's Novartis position peaked at $2.49M in Q3 2013.
  • 1,013 funds tracked by Wall St. Rank held Novartis as of Q1 2018.

Based on Denver Investment Advisors's 13F filing for Q1 2018, filed 10 May 2018.